Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro study of resistance-associated genotypic mutations to nucleoside analogs.

Nucleosides, nucleotides & nucleic acids - 1 Jan 2000

Gashnikova N, Plyasunova O, Kiseleva Y, Fedyuk N, Pokrovsky A

Abstract excerpt

In spite of a rather long period of investigations, the problem of HIV drug resistance remains unsolved, and more that, at present HIV-1 mutants resistant to all known nucleoside inhibitors being used in clinical therapy against the human immunodeficiency syndrome are discovered. In this study we selected HIV-1 mutants resistant to the nucleoside inhibitors of HIV reverse transcriptase (NRTI):...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Didanosine
Share to Drug Resistance, Viral
Share to HIV-1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Reverse Transcriptase

Share to Nucleosides

Share to Reverse Transcriptase Inhibitors

Share to Stavudine

Share to Zidovudine

Source

Identifiers

PMID: 14565328
DOI: 10.1081/NCN-120022720

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro study of resistance-associated genotypic mutations to nucleoside analogs.PMID 14565328Read ↗

Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1.Semantic proximity Read ↗

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.Semantic proximity Read ↗

Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations.Semantic proximity Read ↗

[In vitro selection and phenotyping of HIV-1 mutants resistant to azidothymidine and didanosine].Semantic proximity Read ↗

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.Semantic proximity Read ↗

3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.Semantic proximity Read ↗

3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.Semantic proximity Read ↗

In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.Semantic proximity Read ↗

In vitro selection and characterization of human immunodeficiency virus type 1 resistant to Zidovudine and tenofovir.Semantic proximity Read ↗

3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants.Semantic proximity Read ↗

[Molecular basis and clinical significance of HIV-1 resistance to nucleoside compounds].Semantic proximity Read ↗

Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.